Oncology Strategy and Expands Intellectual Property Foundation for Combination Therapies Across Solid Tumors ATLANTA, GA - ...

Checkpoint inhibitors present significant market opportunities in oncology by enhancing immune responses to cancers like melanoma and lung cancer. Key prospects include emerging therapies targeting ...

Immune checkpoint inhibitors (ICIs) were associated with modest protective effects for patients with asthma, according to new research being presented at the 2026 AAAAI Annual Meeting.

Checkpoint inhibitors are antibody-based cancer therapies that unlock the immune system’s natural ability to fight cancer. These treatments work by blocking special proteins called immune checkpoints, ...

3D rendering of a checkpoint inhibitor binding PD-1, a protein on the surface of an immune T cell. This article is part of an ongoing series on checkpoint inhibitors, a novel cancer immunotherapy.

In a study published in February 2026 in JCO Oncology Practice, investigators from Sweden report that influenza vaccination during treatment with immune checkpoint inhibitors was associated with ...

ImmunityBio Inc (NASDAQ:IBRX) rose 5.6% after announcing what it described as productive regulatory discussions with the ...

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Inflammatory arthritis as a result of immune checkpoint cancer therapy remains a pressing ...

Please provide your email address to receive an email when new articles are posted on . Adding immune checkpoint inhibitors to neoadjuvant chemotherapy benefited certain patients with early-stage ...

ImmunityBio began discussions with SFDA to expand the use of ANKTIVA in combination with checkpoint inhibitors for multiple ...